Acclarent, Inc. Granted Key Patent Covering Balloon Sinuplasty(TM) Technologies
With this latest patent, Acclarent now owns or has exclusive rights to nine issued U.S. patents and over 120 pending U.S. and foreign patent applications.
“Acclarent’s innovative Balloon Sinuplasty(TM) technology has been used by physicians throughout the world to improve the quality of life for thousands of patients suffering from chronic rhinosinusitis,” said Facteau. “Acclarent is committed to continuing its leadership in innovation. This patent protects an important portion of Acclarent’s technology assets and further differentiates Acclarent as a leader in the ENT community. The validation by the USPTO of our invention is a significant step in continuing to provide physicians and patients with access to safe and effective minimally invasive technology.”
ABOUT ACCLARENT, INC.
Acclarent is a medical technology company dedicated to the development of innovative products providing new technologies to further meet the needs of ENT patients.
Acclarent’s initial focus is on achieving the goals of sinus surgery with novel, endoscopic, catheter-based tools – Balloon Sinuplasty(TM) devices. Through the Balloon Sinuplasty(TM) technology and our Relieva(R) product portfolio we offer ENT patients alternatives to conventional endoscopic surgical approaches. Through our core technologies and commitment to innovation, Acclarent will continue to advance novel devices in all areas of ENT. Acclarent markets and sells its products worldwide and has been used by thousands of physicians globally.
SOURCE Acclarent, Inc.